News Release - AHK Korea

News Release
November 30, 2009
Merck Ltd. Korea
Merck Advanced Technologies Ltd.
Haesung-2-Bldg. 15 th Floor
942-10, Daechi-dong, Kangnam-ku
Seoul 135-280, Korea
Phone +82 (02) 2185-3800
Fax +82 (02) 2185-3900
http://www.merck.co.kr
Your Contact
Corporate Communication
Soo-kyung Jeon (2185-3919 / 010-4746-3919)
Mira Jung (2185-3838 / 010-8763-3838)
Merck to Promote Korean Artist through Corporate Calendar Worldwide
November 30, 2009, Seoul, Korea – Merck Limited Korea (President: Mr. Juergen Koenig),
the Korean affiliate of Merck KGaA, Germany-based chemical and pharmaceutical company,
announced on Monday that Merck to Promote Korean Artist through Corporate Calendar
Worldwide.
So, there will be a calendar featuring works by a local artist to be distributed across the world
through Merck network. It will discover local artists less unknown to the public and introduce
their art works printed onto its corporate calendar to worldwide customers, part of the
company’s support program for the culture and art community.
Merck has run the program for years in Germany and elsewhere but it marks the first time
ever that it has selected a Korean artist in the support activity. The first Korean beneficiary
artist is Oh, In-soon, a painter who often employs a bright, vivacious color scheme for her
paintings.
“It is a small start in our support to the culture and art community here, but we are very
excited to see more people will become aware of art works and artists by accessing them
easily in their everyday use of the calendar and this will eventually contribute to the
development of culture and art,” said Mr. Juergen Koenig, president of Merck Korea.
The calendar is due to be sent to Merck’s customers around the globe through Merck’s
network of 60 affiliates overseas.
Merck has so far extended its support to the scientific community in Korea by establishing
awards to encourage promising researchers in fields of liquid crystal and bio technology, and
giving scholarships to medical students.
With the start of the 2010 calendar, Merck said it will keep efforts to discover Korean artists
and promote them around the world.
Page 1 of 2

News Release
About Merck
Merck is a global pharmaceutical and chemical company with total revenues of € 7.6 billion in 2008, a history that began in 1668,
and a future shaped by approximately 33,000 employees in 60 countries. Its success is characterized by innovations and
tradition from entrepreneurial employees. Merck traditionally puts a long-term business beyond a generational period before a
focus on a short-term profit and keeps the chemical and pharmaceutical business under the same umbrella, thereby uniting their
strengths, touching on the reason for Merck to remain one of the most innovative companies for 341 years while it has been
owned by a family since its origin. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck
family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S.
subsidiary Merck & Co. was expropriated and has been an independent company ever since.
About Merck in Korea
Merck Ltd., registered in 1989, and Merck Advanced Technologies Ltd., established in 2002, are the Merck companies in Korea
and operate in pharmaceutical and the chemical industries of Liquid Crystals, Performance & Life Science Chemicals such as
Pigments, Life Science products and Analytics. In 1999, Merck in Korea set up its Korean pharmaceutical operation. This was
integrated with Serono Korea after Merck KGaA’s acquisition of Serono S.A. in 2007. After organizing ourselves, Merck in Korea
set to introduce new products step by step and will continue in the future. In addition, Merck has been increasing the number of
clinical trials in Korea. Merck has a strong relation with R&D in Korea, not only in the medical area but also in the chemical field.
In 2008 Merck KGaA decided to invest EUR 11 million in a new Advanced Technology Center (ATC) to improve Merck’s R&D
and manufacturing capacities by providing high quality products in the rapidly increasing display market, while continuing to
support customers by allowing them to achieve business success through advanced technologies and close relationship in a
rapidly changing display technology. Also, this investment reconfirms Merck’s commitment and responsibility to contribute
innovative solutions for the future success of the Korean display industry. And it is now under construction and will be completed
in early December, 2009.
Page 2 of 2